Briacell Therapeutics Corp (BCT.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 107 | 84 | 15 | 15 | 15 |
| Accounts receivable | 734 | -733 | 5 | -12 | 10 |
| Accounts payable and accrued liabilities | -3,887 | 6,047 | 660 | 249 | N/A |
| Other Working Capital | -1,907 | 7,053 | -3,532 | -391 | -2,282 |
| Other Operating Activity | -23,216 | -36,578 | -20,894 | -12,346 | -5,491 |
| Operating Cash Flow | $-28,171 | $-24,126 | $-23,745 | $-12,484 | $-7,748 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -457 | N/A | N/A | N/A |
| Net Acquisitions | -330 | -225 | N/A | N/A | N/A |
| Purchase Of Investment | -7,316 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-7,646 | $-682 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 0 | -239 |
| Debt Issued | N/A | N/A | N/A | N/A | 216 |
| Debt Repayment | N/A | N/A | N/A | N/A | -310 |
| Common Stock Issued | 44,627 | 4,419 | 4,000 | 0 | 51,622 |
| Common Stock Repurchased | N/A | 0 | -47 | -10,172 | N/A |
| Other Financing Activity | 821 | 0 | 2 | 6,429 | 13,706 |
| Financing Cash Flow | $45,448 | $4,419 | $3,954 | $-3,743 | $64,995 |
| Beginning Cash Position | 862 | 21,251 | 41,042 | 57,269 | 21 |
| End Cash Position | 10,494 | 862 | 21,251 | 41,042 | 57,269 |
| Net Cash Flow | $9,632 | $-20,389 | $-19,791 | $-16,227 | $57,247 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,171 | -24,126 | -23,745 | -12,484 | -7,748 |
| Capital Expenditure | N/A | -457 | N/A | N/A | N/A |
| Free Cash Flow | -28,171 | -24,583 | -23,745 | -12,484 | -7,748 |